B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ATP1A3

MOLECULAR TARGET

ATPase Na+/K+ transporting subunit alpha 3

UniProt: P13637NCBI Gene: 4784 compounds

ATP1A3 (ATPase Na+/K+ transporting subunit alpha 3) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ATP1A3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide.2.087
2Digoxin1.956
3Ouabain1.614
4Digitoxin0.691

About ATP1A3 as a Drug Target

ATP1A3 (ATPase Na+/K+ transporting subunit alpha 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented ATP1A3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ATP1A3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.